Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1995 1
2000 1
2011 1
2012 1
2018 2
2019 1
2020 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial.
Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C, Wanner C, Krane V, Cass A, Craig J, Neal B, Jiang L, Hooi LS, Levin A, Agodoa L, Gaziano M, Kasiske B, Walker R, Massy ZA, Feldt-Rasmussen B, Krairittichai U, Ophascharoensuk V, Fellström B, Holdaas H, Tesar V, Wiecek A, Grobbee D, de Zeeuw D, Grönhagen-Riska C, Dasgupta T, Lewis D, Herrington W, Mafham M, Majoni W, Wallendszus K, Grimm R, Pedersen T, Tobert J, Armitage J, Baxter A, Bray C, Chen Y, Chen Z, Hill M, Knott C, Parish S, Simpson D, Sleight P, Young A, Collins R; SHARP Investigators. Baigent C, et al. Lancet. 2011 Jun 25;377(9784):2181-92. doi: 10.1016/S0140-6736(11)60739-3. Epub 2011 Jun 12. Lancet. 2011. PMID: 21663949 Free PMC article. Clinical Trial.
Diverse molecular causes of unsolved autosomal dominant tubulointerstitial kidney diseases.
Wopperer FJ, Knaup KX, Stanzick KJ, Schneider K, Jobst-Schwan T, Ekici AB, Uebe S, Wenzel A, Schliep S, Schürfeld C, Seitz R, Bernhardt W, Gödel M, Wiesener A, Popp B, Stark KJ, Gröne HJ, Friedrich B, Weiß M, Basic-Jukic N, Schiffer M, Schröppel B, Huettel B, Beck BB; Genomics England Research Consortium; Sayer JA, Ziegler C, Büttner-Herold M, Amann K, Heid IM, Reis A, Pasutto F, Wiesener MS. Wopperer FJ, et al. Among authors: schurfeld c. Kidney Int. 2022 Aug;102(2):405-420. doi: 10.1016/j.kint.2022.04.031. Epub 2022 May 26. Kidney Int. 2022. PMID: 35643372 Free article.
Multimodal lipid-lowering treatment in pediatric patients with homozygous familial hypercholesterolemia-target attainment requires further increase of intensity.
Klaus G, Taylan C, Büscher R, Schmitt CP, Pape L, Oh J, Driemeyer J, Galiano M, König J, Schürfeld C, Spitthöver R, Schaefer JR, Weber LT, Heibges A, Klingel R. Klaus G, et al. Among authors: schurfeld c. Pediatr Nephrol. 2018 Jul;33(7):1199-1208. doi: 10.1007/s00467-018-3906-6. Epub 2018 Mar 3. Pediatr Nephrol. 2018. PMID: 29502162
[Color-coded duplex sonography in the diagnosis of kidney diseases].
Schürfeld C, Schleiffer T, Klooker P, Baldus M, Claus B, Wildburg G, Brass H. Schürfeld C, et al. Dtsch Med Wochenschr. 1995 Jun 23;120(25-26):926-34. doi: 10.1055/s-2008-1055429. Dtsch Med Wochenschr. 1995. PMID: 7600930 Review. German. No abstract available.
Real-world study: Escalating targeted lipid-lowering treatment with PCSK9-inhibitors and lipoprotein apheresis.
Spitthöver R, Röseler T, Julius U, Heigl F, Schettler VJJ, Kühn R, Leebmann J, Raabe A, Knittel M, Schürfeld C, Moesenthin M, Bernhardt WM, Röseler E, Ketteler M, Heibges A, Klingel R. Spitthöver R, et al. Among authors: schurfeld c. J Clin Apher. 2019 Aug;34(4):423-433. doi: 10.1002/jca.21695. Epub 2019 Feb 28. J Clin Apher. 2019. PMID: 30817043
Cardiovascular Outcome of Pediatric Patients With Bi-Allelic (Homozygous) Familial Hypercholesterolemia Before and After Initiation of Multimodal Lipid Lowering Therapy Including Lipoprotein Apheresis.
Taylan C, Driemeyer J, Schmitt CP, Pape L, Büscher R, Galiano M, König J, Schürfeld C, Spitthöver R, Versen A, Koziolek M, Marsen TA, Stein H, Schaefer JR, Heibges A, Klingel R, Oh J, Weber LT, Klaus G. Taylan C, et al. Among authors: schurfeld c. Am J Cardiol. 2020 Dec 1;136:38-48. doi: 10.1016/j.amjcard.2020.09.015. Epub 2020 Sep 16. Am J Cardiol. 2020. PMID: 32946862
Investigations of the frequency of DNA strand breakage and cross-linking and of sister chromatid exchange frequency in the lymphocytes of patients with multiple myeloma undergoing cytostatic therapy with melphalan and prednisone.
Popp W, Vahrenholz C, Schürfeld C, Schmieding W, Hoster M, Bach I, Norpoth K. Popp W, et al. Among authors: schurfeld c. Carcinogenesis. 1992 Nov;13(11):2191-5. doi: 10.1093/carcin/13.11.2191. Carcinogenesis. 1992. PMID: 1423893